glp-1 r retatrutide vs Semaglutide and Tirzepatide: GLP-3 Facts explained Retatrutide Promises Big Weight Loss,

The goal is not simply to become lighter

Our Reviews of Popular GLP-1 Alternatives Curious to learn more

The reality is more nuanced and considerably more interesting

At 48 weeks, weight loss was dose-dependent: the 12 mg group achieved approximately 24.2% mean weight loss, which was meaningfully higher than the approximately 15% reported for semaglutide 2.4 mg in the STEP 1 trial and approximately 20-22% for tirzepatide in the SURMOUNT trials

This has led researchers to investigate medications that modulate these systems, including the glucagon-like peptide-1 (GLP-1) receptor agonists originally developed for type 2 diabetes and obesity management